Effects of Chemically Characterized Fractions from Aerial Parts of Echinacea purpurea and E. angustifolia on Myelopoiesis in Rats

Abstract

Echinacea species are used for beneficial effects on immune function, and various prevalent phytochemicals have immunomodulatory effects. Using a commercial E. purpurea (L.) Moench product, we have evaluated the myelopoietic effect on bone marrow of rats treated with various extracts and correlated this with their chemical class composition. Granulocyte/macrophage-colony forming cells (GM-CFCs) from femurs of female Sprague-Dawley rats were assessed at 24 h after 7 daily oral treatments. A 75 % ethanolic extract at 50 mg dried weight (derived from 227 mg aerial parts) per kg body weight increased GM-CFCs by 70 % but at 100 mg/kg was without effect. Ethanolic extracts from aerial parts of E. angustifolia DC. var. angustifolia and E. purpurea from the USDA North Central Regional Plant Introduction Station increased GM-CFCs by 3- and 2-fold, respectively, at 200 mg/kg (∼ 1400 mg/kg plant material). Extract from another USDA E. angustifolia was inactive. Proton and APT NMR, MS, and TLC indicated alkylamides and caffeic-acid derivatives (CADs) present in ethanolic extracts of both the commercial and USDA-derived material. Cichoric and caftaric acids were prominent in both E. purpurea ethanolic extracts but absent in E. angustifolia. Aqueous extract of the commercial material exhibited polysaccharide and CAD signatures and was without effect on GM-CFCs. A methanol-CHCl₃ fraction of commercial source, also inactive, was almost exclusively 1 : 4 nonanoic : decanoic acids, which were also abundant in commercial ethanolic extract but absent from USDA material. In conclusion, we have demonstrated an ethanol-extractable myelostimulatory activity in Echinacea aerial parts that, when obtained from commercial herbal supplements, may be antagonized by medium-chain fatty acids presumably derived from a non-plant additive.

Echinacea angustifolia - Echinacea purpurea - Asteraceae - immune function - herbal supplement - medium-chain triglyceride additive

References

• 1 Wills R B H, Bone K, Morgan M. Herbal products: active constituents, modes of action and quality control.  Nutrition Res Rev. 2000;  13 47-77
• 2 Barnes J, Anderson L A, Gibbons S, Phillipson J D. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties.  J Pharm Pharmacol. 2005;  57 929-954
• 3 Gertsch J, Schoop R, Kuenzle U, Suter A. Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways.  FEBS Lett. 2004;  577 563-569
• 4 Chen Y, Fu T, Tao T, Yang J, Chang Y, Wang M, Kim L, Qu L, Cassady J, Scalzo R, Wang X. Macrophage activating effects of new alkamides from the roots of Echinacea species.  J Nat Prod. 2005;  68 773-776
• 5 Matthias A, Banbury L, Stevenson L M, Bone K M, Leach D N, Lehmann R P. Alkylamides from Echinacea modulate induced immune responses in macrophages.  Immunol Invest. 2007;  36 117-130
• 6 Birt D F, Widrlechner M P, Lalone C A, Wu L, Bae J, Solco A K, Kraus G A, Murphy P A, Wurtele E S, Leng Q, Hebert S C, Maury W J, Price J P. Echinacea in infection.  Am J Clin Nutr. 2008;  87 488S-492S
• 7 Woelkart K, Bauer R. The role of alkamides as an active principle of Echinacea.  Planta Med. 2007;  73 615-623
• 8 Luettig B, Steinmuller C, Gifford G E, Wagner H, Lohmann-Matthes M L. Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea.  J Natl Cancer Inst. 1989;  81 669-675
• 9 Brovelli E A, Rua D, Roh-Schmidt H, Chandra A, Lamont E, Noratto G D. Human gene expression as a tool to determine horticultural maturity in a bioactive plant (Echinacea purpurea L. Moench).  J Agric Food Chem. 2005;  53 8156-8161
• 10 Hinz B, Woelkart K, Bauer R. Alkamides from Echinacea inhibit cyclooxygenase-2 activity in human neuroglioma cells.  Biochem Biophys Res Commun. 2007;  360 441-446
• 11 Zhai Z, Solco A, Wu L, Wurtele E S, Kohut M L, Murphy P A, Cunnick J E. Echinacea increases arginase activity and has anti-inflammatory properties in RAW 264.7 macrophage cells, indicative of alternative macrophage activation.  J Ethnopharmacol. 2009;  122 76-85
• 12 Delorme D, Miller S C. Dietary consumption of Echinacea by mice afflicted with autoimmune (type I) diabetes: effect of consuming the herb on hemopoietic and immune cell dynamics.  Autoimmunity. 2005;  38 453-461
• 13 Miller S C, Sun L Z- Y. Effect of dietary administration of Echinacea on immune and hemopoietic cell lineages in murine spleen and bone marrow.  FASEB J. 1998;  12 A874
• 14 Binns S E, Livesey J F, Arnason J T, Baum B R. Phytochemical variation in Echinacea from roots and flowerheads of wild and cultivated populations.  J Agric Food Chem. 2002;  50 3673-3687
• 15 Wu L, Dixon P M, Nikolau B J, Kraus G A, Widrlechner M P, Wurtele E S. Metabolic profiling of Echinacea genotypes and a test of alternative taxonomic treatments.  Planta Med. 2009;  75 178-183
• 16 Raduner S, Majewska A, Chen J Z, Xie X Q, Hamon J, Faller B, Altmann K H, Gertsch J. Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects.  J Biol Chem. 2006;  281 14192-14206
• 17 Christensen K B, Petersen R K, Petersen S, Kristiansen K, Christensen L P. Activation of PPARgamma by metabolites from the flowers of purple coneflower (Echinacea purpurea).  J Nat Prod. 2009;  72 933-937
• 18 Spelman K, Iiams-Hauser K, Cech N B, Taylor E W, Smirnoff N, Wenner C A. Role for PPARgamma in IL-2 inhibition in T cells by Echinacea-derived undeca-2E-ene-8,10-diynoic acid isobutylamide.  Int Immunopharmacol. 2009;  9 1260-1264
• 19 Jiang S, Fu Y, Williams J, Wood J, Pandarinathan L, Avraham S, Makriyannis A, Avraham H K. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.  PLoS ONE. 2007;  2 e641
• 20 Valk P, Verbakel S, Vankan Y, Hol S, Mancham S, Ploemacher R, Mayen A, Lowenberg B, Delwel R. Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells.  Blood. 1997;  90 1448-1457
• 21 Patinkin D, Milman G, Breuer A, Fride E, Mechoulam R. Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation.  Eur J Pharmacol. 2008;  595 1-6
• 22 Prost S, Le Dantec M, Auge S, Le Grand R, Derdouch S, Auregan G, Deglon N, Relouzat F, Aubertin A M, Maillere B, Dusanter-Fourt I, Kirszenbaum M. Human and simian immunodeficiency viruses deregulate early hematopoiesis through a Nef/PPARgamma/STAT5 signaling pathway in macaques.  J Clin Invest. 2008;  118 1765-1775
• 23 Woelkart K, Linde K, Bauer R. Echinacea for preventing and treating the common cold.  Planta Med. 2008;  74 633-637
• 24 Turner R B, Bauer R, Woelkart K, Hulsey T C, Gangemi J D. An evaluation of Echinacea angustifolia in experimental rhinovirus infections.  N Engl J Med. 2005;  353 341-348
• 25 Barrett B, Brown R, Rakel D, Mundt M, Bone K, Barlow S, Ewers T. Echinacea for treating the common cold.  Ann Intern Med. 2010;  153 769-777
• 26 Heydinger J A. Physical properties of medium-chain triglycerides and application in food. In: Widlak N, editor Physical properties of fats, oils, and emulsifiers. Champaign, Il: AOCS Press; 1999: 220-225
• 27 Frédérich M, Jansen C, de Tullio P, Tits M, Demoulin V, Angenot L. Metabolomic analysis of Echinacea spp. by 1H nuclear magnetic resonance spectrometry and multivariate data analysis technique.  Phytochem Anal. 2010;  21 61-65
• 28 Politi M, Zloh M, Pintado M, Castro P, Heinrich M, Prieto J. Direct metabolic fingerprinting of commercial herbal tinctures by nuclear magnetic resonance spectroscopy and mass spectrometry.  Phytochem Anal. 2009;  20 328-334
• 29 Tamta H, Pugh N D, Balachandran P, Moraes R, Sumiyanto J, Pasco D S. Variability in in vitro macrophage activation by commercially diverse bulk Echinacea plant material is predominantly due to bacterial lipoproteins and lipopolysaccharides.  J Agric Food Chem. 2008;  56 10552-10556
• 30 Reich E, Schibli A, DeBatt A. Validation of high-performance thin-layer chromatographic methods for the identification of botanicals in a cGMP environment.  J AOAC Intl. 2008;  91 119S-150S
• 31 Kraus G A, Bae J, Wu L, Wurtele E. Synthesis and natural distribution of anti-inflammatory alkamides from Echinacea.  Molecules. 2006;  11 758-767
• 32 CAMAG .Application notes F-24A and F-24B-HPTLC. Identification of Echinacea-phenolics and alkylamides. Available at http://www.camag.com/downloads/protected/herbals/F-24a_echinacea_phenolics.pdf and /F24B_echinacea_alkylamides.pdf Accessed January 7, 2011
• 33 Matovic N, Matthias A, Gertsch J, Raduner S, Bone K M, Lehmann R P, Devoss J J. Stereoselective synthesis, natural occurrence and CB(2) receptor binding affinities of alkylamides from herbal medicines such as Echinacea sp.  Org Biomol Chem. 2007;  5 169-174
• 34 Kale V M, Aycock M M, Wilbanks M S, Perkins E, Inouye L S, Meyer S A. Hematotoxicity of munitions compound hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) and environmental degradation product MNX.  The Toxicologist. 2007;  96 35